News
InvestorsHub on MSN5h
Mineralys Therapeutics Shares Climb on Strong Results from Kidney Disease TrialShares of Mineralys Therapeutics Inc. (NASDAQ:MLYS) jumped 7.9% following the release of promising topline data from the ...
Liver transplant is a lifesaving surgery, but a significant number of patients experience organ rejection or other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback